Complete ophthalmoplegia secondary to idiopathic intracranial hypertension managed successfully with dural sinus stenting: A case and systematic review

2021 ◽  
Vol 209 ◽  
pp. 106910
Author(s):  
Mansour Mathkour ◽  
Tyler Scullen ◽  
Mitchell D. Kilgore ◽  
Edna E. Gouveia ◽  
Julie Chu ◽  
...  
2016 ◽  
Vol 159 (1) ◽  
pp. 33-49 ◽  
Author(s):  
Aristotelis V. Kalyvas ◽  
Mark Hughes ◽  
Christos Koutsarnakis ◽  
Demetrios Moris ◽  
Faidon Liakos ◽  
...  

2016 ◽  
Vol 9 (12) ◽  
pp. 1228-1232 ◽  
Author(s):  
Amgad El Mekabaty ◽  
Nancy A Obuchowski ◽  
Mark G Luciano ◽  
Seby John ◽  
Charlotte Y Chung ◽  
...  

BackgroundVenous sinus stenting for dural sinus stenoses is an emerging alternative to cerebrospinal fluid diversion in cases of medically refractory idiopathic intracranial hypertension. Juxta-stent ‘re-stenoses’ have been reported and managed alternatively with ventricular shunting or stent revision. Identification of factors that might predispose patients to recurrent narrowing may help to select or exclude patients with idiopathic intracranial hypertension for venous sinus stenting.MethodsWe retrospectively reviewed a prospectively maintained database spanning December 2011 to May 2015 of all patients with idiopathic intracranial hypertension who were screened for possible venous sinus stenting, including only patients who received a stent, noting symptomatic improvements, changes in opening lumbar puncture pressure, demographic characteristics, and any subsequent intervention after stent placement. Fisher's exact test and logistic regression were used to test each of seven potential predictors for retreatment.ResultsThere were eight revisions in 31 patients (25.8%). Among Caucasians, 8.0% required a revision compared with 100% of African-Americans (p<0.001). The c-index for race was 0.857. Body mass index (BMI) was also a significant predictor of revision (p=0.031): among class III obese patients the revision rate was 46.2% compared with 16.7% among class I and II obese patients and 0% among overweight to normal weight patients.ConclusionsBMI was a significant predictor of revision, suggesting that higher BMI may have a higher risk of revision. The small number of African-Americans in the study makes interpretation of the practical significance of the revision rate in these patients uncertain. None of the other studied factors was statistically significant.


Author(s):  
Aristotelis Kalyvas ◽  
Eleftherios Neromyliotis ◽  
Christos Koutsarnakis ◽  
Spyridon Komaitis ◽  
Evangelos Drosos ◽  
...  

2020 ◽  
pp. 10.1212/CPJ.0000000000001022
Author(s):  
Mattia Sansone ◽  
Michelangelo De Angelis ◽  
Leonilda Bilo ◽  
Vincenzo Bonavita ◽  
Roberto De Simone

The intracranial pressure (ICP) show large daily fluctuation, mainly due to postural changes and physical activity (e.g. it goes up to 470 mmH2O under Valsalva manoeuvre1). Consequently, the dural sinus must be sufficiently rigid in order to avoid its collapse during cerebrospinal fluid (CSF) pressure peaks. Hereby, we describe a patient with collapsible dural sinus associated with an intracranial hypertension syndrome without a detectable raised ICP, suggesting that a number of crucial assumptions on idiopathic intracranial hypertension with (IIH) or without papilledema (IIHWOP) might be discussed.


2015 ◽  
Vol 0 (0) ◽  
pp. 0
Author(s):  
IrfanYousuf Wani ◽  
Sawan Verma ◽  
Mushtaq Wani ◽  
Ravouf Asimi ◽  
Saleem Sheikh ◽  
...  

2020 ◽  
Vol 63 (2) ◽  
pp. E123-E128
Author(s):  
Warren Y. L. Sun ◽  
Noah J. Switzer ◽  
Jerry T. Dang ◽  
Richdeep Gill ◽  
Xinzhe Shi ◽  
...  

2012 ◽  
Vol 116 (3) ◽  
pp. 538-548 ◽  
Author(s):  
David A. Kumpe ◽  
Jeffrey L. Bennett ◽  
Joshua Seinfeld ◽  
Victoria S. Pelak ◽  
Ashish Chawla ◽  
...  

Object The use of unilateral dural sinus stent placement in patients with idiopathic intracranial hypertension (IIH) has been described by multiple investigators. To date there is a paucity of information on the angiographic and hemodynamic outcome of these procedures. The object of this study was to define the clinical, angiographic, and hemodynamic outcome of placement of unilateral dural sinus stents to treat intracranial venous hypertension in a subgroup of patients meeting the diagnostic criteria for IIH. Methods Eighteen consecutive patients with a clinical diagnosis of IIH were treated with unilateral stent placement in the transverse-sigmoid junction region. All patients had papilledema. All 12 female patients had headaches; 1 of 6 males had headaches previously that disappeared after weight loss. Seventeen patients had elevated opening pressures at lumbar puncture. Twelve patients had opening pressures of 33–55 cm H2O. All patients underwent diagnostic cerebral arteriography that showed venous outflow compromise by filling defects in the transverse-sigmoid junction region. All patients underwent intracranial selective venous pressure measurements across the filling defects. Follow-up arteriography was performed in 16 patients and follow-up venography/venous pressure measurements were performed in 15 patients. Results Initial pressure gradients across the filling defects ranged from 10.5 to 39 mm Hg. Nineteen stent procedures were performed in 18 patients. One patient underwent repeat stent placement for hemodynamic failure. Pressure gradients were reduced in every instance and ranged from 0 to 7 mm Hg after stenting. Fifteen of 16 patients in whom ophthalmological follow-up was performed experienced disappearance of papilledema. Follow-up arteriography in 16 patients at 5–99 months (mean 25.3 months, median 18.5 months) showed patency of all stents without in-stent restenosis. Two patients had filling defects immediately above the stent. Four other patients developed transverse sinus narrowing above the stent without filling defects. One of these patients underwent repeat stent placement because of hemodynamic deterioration. Two of the other 3 patients had hemodynamic deterioration with recurrent pressure gradients of 10.5 and 18 mm Hg. Conclusions All stents remained patent without restenosis. Stent placement is durable and successfully eliminates papilledema in appropriately selected patients. Continuing hemodynamic success in this series was 80%, and was 87% with repeat stent placement in 1 patient.


Sign in / Sign up

Export Citation Format

Share Document